Bio Green Med Solution, Inc. (BGMS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 300K 600K 900K Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 0 Q3 '22: 0 Q4 '22: 0 Q1 '23: 0 Q2 '23: 373K Q3 '23: 16K Q4 '23: 31K Q1 '24: 29K Q2 '24: 4K Q3 '24: 10K Q4 '24: 0 Q3 '25: 81K Q4 '25: 666K Q1 '26: 778K Q2 '26: 336K Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -6M Q4 '21: -6.3M Q1 '22: -6.6M Q2 '22: -5.8M Q3 '22: -6.5M Q4 '22: -8.8M Q1 '23: -7.3M Q2 '23: -5.9M Q3 '23: -6.8M Q4 '23: -5.4M Q1 '24: -4.4M Q2 '24: -3.6M Q3 '24: -2.2M Q4 '24: -1.8M Q1 '25: -822K Q2 '25: -68K Q3 '25: -992K Q4 '25: -1.1M Q1 '26: -246K Q2 '26: -418K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q3 '21: -5M Q4 '21: -5.1M Q1 '22: -4.1M Q2 '22: -4.6M Q3 '22: -5.1M Q4 '22: -7.4M Q1 '23: -5.8M Q2 '23: -5.4M Q3 '23: -6M Q4 '23: -5.3M Q1 '24: -2.9M Q2 '24: -3.3M Q3 '24: -2M Q4 '24: -3.1M Q1 '25: -81K Q2 '25: -1.3M Q3 '25: -988K Q4 '25: -611K Q1 '26: -197K Q2 '26: -405K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -6.2M Q4 '21: -4.5M Q1 '22: -6.8M Q2 '22: -1.9M Q3 '22: -7M Q4 '22: -5.2M Q1 '23: -6.9M Q2 '23: -1.3M Q3 '23: -4M Q4 '23: -3.9M Q1 '24: -483K Q2 '24: -3.1M Q3 '24: -3.1M Q4 '24: -1.4M Q1 '25: -3.2M Q2 '25: -1.1M Q3 '25: -434K Q4 '25: -33K Q1 '26: -278K Q2 '26: -352K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q4 '19: -1.1M Q1 '20: -2.8M Q2 '20: -1.8M Q3 '20: -2.2M Q4 '20: -1.2M Q1 '21: -3.6M Q2 '21: -4.3M Q3 '21: -6.2M Q4 '21: -4.6M Q1 '22: -6.8M Q2 '22: -1.9M Q3 '22: -7M Q4 '22: -5.2M Q1 '23: -6.9M Q2 '23: -1.3M Q3 '23: -4M Q4 '23: -3.9M Q3 '24: -3.1M Q1 '26: -279K Q2 '26: -352K Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 8M 16M 24M Q3 '12: 8.4M Q1 '13: 9.8M Q2 '13: 13.9M Q3 '13: 17.8M Q1 '14: 19.5M Q2 '14: 22.6M Q1 '21: 7M Q2 '21: 9.2M Q3 '21: 9.4M Q1 '22: 10M Q2 '22: 10.1M Q3 '22: 12.3M Q1 '23: 12.5M Q2 '23: 12.6M Q3 '24: 44.7K Q1 '25: 365.2K Q2 '25: 1.4M Q3 '25: 1.9M Q1 '26: 5.5M Q2 '26: 5.6M Q1 '13 Q1 '14 Q2 '21 Q2 '22 Q2 '23 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-240.00 -160.00 -80.00 0.00 80.00 160.00 240.00 Q2 '19: -5.25 Q3 '19: -7.34 Q4 '19: -9.93 Q1 '20: -8.64 Q2 '20: -7.09 Q3 '20: -5.29 Q4 '20: -4.14 Q1 '21: -3.16 Q2 '21: -3.14 Q3 '21: -3.21 Q4 '21: -2.11 Q1 '22: -2.03 Q2 '22: -1.93 Q3 '22: -1.81 Q4 '22: -27.25 Q4 '24: -230.70 Q1 '25: -228.43 Q2 '25: -57.23 Q3 '25: -14.74 Q4 '25: -5.88 Q3 '19 Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q1 '25 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.